{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T15:03:28Z","timestamp":1725807808264},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1996,8,1]],"date-time":"1996-08-01T00:00:00Z","timestamp":838857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[1996,8]]},"DOI":"10.1007\/bf02505254","type":"journal-article","created":{"date-parts":[[2006,10,11]],"date-time":"2006-10-11T12:34:11Z","timestamp":1160570051000},"page":"554-558","source":"Crossref","is-referenced-by-count":9,"title":["Interleukin-1\u03b2 upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT)"],"prefix":"10.1007","volume":"288","author":[{"given":"Jutta M.","family":"Rox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette","family":"Reinartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02505254_CR1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/1523-1747.ep12504901","volume":"95","author":"J Baird","year":"1990","unstructured":"Baird J, Lazarus GS, Belin D, Vassalli J-D, Busso N, Gubler P, Jensen PJ (1990) mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol 95:548\u2013552","journal-title":"J Invest Dermatol"},{"key":"BF02505254_CR2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0140-6736(91)92168-2","volume":"337","author":"JNWN Barker","year":"1991","unstructured":"Barker JNWN, Mitra RS, Griffiths CEM, Dixit VM, Nickoloff BJ (1991) Keratinocytes as initiators of inflammation. Lancet 337:211\u2013214","journal-title":"Lancet"},{"key":"BF02505254_CR3","doi-asserted-by":"crossref","first-page":"9437","DOI":"10.1016\/S0021-9258(19)76559-4","volume":"263","author":"RA Black","year":"1988","unstructured":"Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS, Wignall J, Conlon PJ, Cosman D, Hopp TP, Mochizuki DY (1988) Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 263:9437\u20139442","journal-title":"J Biol Chem"},{"key":"BF02505254_CR4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","volume":"24","author":"E Borenfreund","year":"1985","unstructured":"Borenfreund E, Puerner JA (1985) Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24:119\u2013124","journal-title":"Toxicol Lett"},{"key":"BF02505254_CR5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.106.3.761","volume":"106","author":"P Boukamp","year":"1988","unstructured":"Boukamp P, Petrusevska RT, Breitkreuz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761\u2013771","journal-title":"J Cell Biol"},{"key":"BF02505254_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-1759(93)90384-J","volume":"162","author":"F Buessecker","year":"1993","unstructured":"Buessecker F, Reinartz J, Schirmer U, Kramer MD (1993) Enzyme-linked immunosorbent assays for plasminogen activators. J Immunol Methods 162:193\u2013200","journal-title":"J Immunol Methods"},{"key":"BF02505254_CR7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-0625.1995.tb00060.x","volume":"4","author":"F Buessecker","year":"1995","unstructured":"Buessecker F, Reinartz J, Kramer MD (1995) tPA of human keratinocytes: contribution to cell-surface-associated plasminogen activation and upregulation by retinoic acid. Exp Dermatol 4:357\u2013364","journal-title":"Exp Dermatol"},{"key":"BF02505254_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2133.1992.tb08400.x","volume":"126","author":"SM Burge","year":"1992","unstructured":"Burge SM, Marshall JM, Cederholm-Williams SA (1992) Plasminogen binding sites in normal human skin. Br J Dermatol 126:35\u201341","journal-title":"Br J Dermatol"},{"key":"BF02505254_CR9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","volume":"162","author":"P Chomczynski","year":"1986","unstructured":"Chomczynski P, Sacchi N (1986) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biocehm 162:156\u2013159","journal-title":"Anal Biocehm"},{"key":"BF02505254_CR10","unstructured":"Dan\u00f6 K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1989) Plasminogen activators and cancer. Adv Cancer Res 1\u2013225"},{"key":"BF02505254_CR11","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1182\/blood.V77.8.1627.1627","volume":"77","author":"CA Dinarello","year":"1991","unstructured":"Dinarello CA (1991) Interleukin-1 and interleukin-1 antagonism. Blood 77:1627\u20131652","journal-title":"Blood"},{"key":"BF02505254_CR12","doi-asserted-by":"crossref","first-page":"68S","DOI":"10.1111\/1523-1747.ep12875154","volume":"94","author":"SK Dower","year":"1990","unstructured":"Dower SK, Qwarnstrom EE, Page RC, Blanton RA, Kupper TS, Raines E, Ross R, Sims JE (1990) Biology of the interleukin-1 receptor. J Invest Dermatol 94:68S-73S","journal-title":"J Invest Dermatol"},{"key":"BF02505254_CR13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0003-2697(84)90002-2","volume":"139","author":"GJ Finlay","year":"1984","unstructured":"Finlay GJ, Baguley BC, Wilson WR (1984) A semiautomated microculture method for investigating growth inhibitory effects of cytotoxic compounds on exponentially growing carcinoma cells. Anal Biochem 139:272\u2013277","journal-title":"Anal Biochem"},{"issue":"Suppl 162","key":"BF02505254_CR14","first-page":"1","volume":"42","author":"P Friberger","year":"1982","unstructured":"Friberger P (1982) Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikreinkinin systems. Scand J Clin Lab Invest 42 [Suppl 162]:1\u201398","journal-title":"Scand J Clin Lab Invest"},{"key":"BF02505254_CR15","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1172\/JCI112141","volume":"76","author":"LC Gahring","year":"1985","unstructured":"Gahring LC, Buckley A, Daynes RA (1985) Presence of epidermal-derived thymocyte activating factor\/interleukin 1 in normal human stratum corneum. J Clin Invest 76:1585\u20131591","journal-title":"J Clin Invest"},{"key":"BF02505254_CR16","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2133.1993.tb00254.x","volume":"128","author":"HM Gissler","year":"1993","unstructured":"Gissler HM, Frank R, Kramer MD (1993) Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis. Br J Dermatol 128:612\u2013618","journal-title":"Br J Dermatol"},{"key":"BF02505254_CR17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archderm.1989.01670190059006","volume":"125","author":"SA Grando","year":"1989","unstructured":"Grando SA, Glukhenky BT, Drannik GN, Epshtein EV, Kostromin AP, Korostash TA (1989) Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid. Arch Dermatol 125:925\u2013930","journal-title":"Arch Dermatol"},{"key":"BF02505254_CR18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/1523-1747.ep12464827","volume":"88","author":"J Grondahl-Hansen","year":"1987","unstructured":"Grondahl-Hansen J, Ralfkiaer E, Nielsen LS, Kristensen P, Frentz G, Dan\u00f6 K (1987) Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin. J Invest Dermatol 88:28\u201332","journal-title":"J Invest Dermatol"},{"key":"BF02505254_CR19","first-page":"279","volume":"3","author":"TJR Harris","year":"1986","unstructured":"Harris TJR, Patel T, Marston FAP, Little S, Emtage JS, Opdenakker G, Volckaert G, Rombauts W, Billiau A, De Somer P (1986) Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in Escherichia coli. Mol Biol Med 3:279\u2013292","journal-title":"Mol Biol Med"},{"key":"BF02505254_CR20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/1523-1747.ep12522590","volume":"81","author":"K Hashimoto","year":"1983","unstructured":"Hashimoto K, Singer KH, Lide WB, Shafran K, Webber P, Morioka S, Lazarus GS (1983) Plasminogen activator in cultured human epidermal cells. J Invest Dermatol 81:424\u2013429","journal-title":"J Invest Dermatol"},{"key":"BF02505254_CR21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0014-4827(90)90131-S","volume":"187","author":"P Jensen","year":"1990","unstructured":"Jensen P, John M, Baird J (1990) Urokinase and tissue type plasminogen activators in human keratinocyte culture. Exp Cell Res 187:162\u2013169","journal-title":"Exp Cell Res"},{"key":"BF02505254_CR22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/1523-1747.ep12461494","volume":"90","author":"PJ Jensen","year":"1988","unstructured":"Jensen PJ, Baird J, Morioka S, Lessin S, Lazarus GS (1988) Epidermal plasminogen activator is abnormal in cutaneous lesions. J Invest Dermatol 90:777\u2013782","journal-title":"J Invest Dermatol"},{"key":"BF02505254_CR23","doi-asserted-by":"crossref","first-page":"16372","DOI":"10.1016\/S0021-9258(18)37603-8","volume":"263","author":"SA Jobling","year":"1988","unstructured":"Jobling SA, Auron PE, Gurka G, Webb AC, McDonald B, Rosenwasser LJ, Gehrke L (1988) Biological activity and receptor binding of human prointerleukin-1 beta and subpeptides. J Biol Chem 263: 16372\u201316378","journal-title":"J Biol Chem"},{"key":"BF02505254_CR24","first-page":"201","volume":"44","author":"A Kapp","year":"1993","unstructured":"Kapp A (1993) Die Rolle von Zytokinen f\u00fcr die Pathogenese der Psoriasis. Hautarzt 44:201\u2013207","journal-title":"Hautarzt"},{"key":"BF02505254_CR25","first-page":"131","volume":"376","author":"MD Kramer","year":"1995","unstructured":"Kramer MD, Reinartz J, Schaefer B (1995) Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences. Biol Chem Hoppe Seyler 376:131\u2013141","journal-title":"Biol Chem Hoppe Seyler"},{"key":"BF02505254_CR26","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1172\/JCI114907","volume":"86","author":"TS Kupper","year":"1990","unstructured":"Kupper TS (1990) Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest 86: 1783\u20131789","journal-title":"J Clin Invest"},{"key":"BF02505254_CR27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1172\/JCI113090","volume":"80","author":"TS Kupper","year":"1987","unstructured":"Kupper TS, Chua AO, Flood P, McGuire J, Gubler U (1987) Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest 80: 430\u2013436","journal-title":"J Clin Invest"},{"key":"BF02505254_CR28","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI115067","volume":"87","author":"H Mizutani","year":"1991","unstructured":"Mizutani H, Black R, Kupper TS (1991) Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. J Clin Invest 87:1066\u20131071","journal-title":"J Clin Invest"},{"key":"BF02505254_CR29","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1084\/jem.174.4.821","volume":"174","author":"H Mizutani","year":"1991","unstructured":"Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS (1991) Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med 174:821\u2013825","journal-title":"J Exp Med"},{"key":"BF02505254_CR30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0014-4827(85)90093-X","volume":"161","author":"S Morioka","year":"1985","unstructured":"Morioka S, Jensen PJ, Lazarus GS (1985) Human epidermal plasminogen activator. Characterization, localization, and modulation. Exp Cell Res 161:364\u2013372","journal-title":"Exp Cell Res"},{"key":"BF02505254_CR31","doi-asserted-by":"crossref","first-page":"121S","DOI":"10.1111\/1523-1747.ep12874991","volume":"95","author":"EP Prens","year":"1990","unstructured":"Prens EP, Benne K, Van Damme J, Bakkus M, Brakel K, Benner R, van Joost Th (1990) Interleukin-1 and Interleukin-6 in psoriasis. J Invest Dermatol 95:121S-124S","journal-title":"J Invest Dermatol"},{"key":"BF02505254_CR32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/excr.1993.1238","volume":"208","author":"J Reinartz","year":"1993","unstructured":"Reinartz J, Batrla R, Boukamp P, Fusenig N, Kramer MD (1993) Binding and activation of plasminogen at the surface of human keratinocytes. Exp Cell Res 208:197\u2013208","journal-title":"Exp Cell Res"},{"key":"BF02505254_CR33","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/BF00373352","volume":"284","author":"J Reinartz","year":"1993","unstructured":"Reinartz J, N\u00e4her H, May H, Kramer MD (1993) Plasminogen activation in lesional skin of pemphigus vulgaris typ Neumann. Arch Dermatol Res 284:432\u2013439","journal-title":"Arch Dermatol Res"},{"key":"BF02505254_CR34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/1523-1747.ep12371792","volume":"102","author":"EM Spiers","year":"1994","unstructured":"Spiers EM, Lazarus GS, Lyons Giordano B (1994) Expression of plasminogen activator enzymes in psoriatic epidermis. J Invest Dermatol 102:333\u2013338","journal-title":"J Invest Dermatol"},{"key":"BF02505254_CR35","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/356768a0","volume":"356","author":"NA Thornberry","year":"1992","unstructured":"Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, et al (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356:768\u2013774","journal-title":"Nature"},{"key":"BF02505254_CR36","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI115405","volume":"88","author":"J-D Vassalli","year":"1991","unstructured":"Vassalli J-D, Sappino A-P, Belin D (1991) The plasminogen activator\/plasmin system. J Clin Invest 88:1067\u20131072","journal-title":"J Clin Invest"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02505254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02505254\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02505254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T02:26:09Z","timestamp":1627871169000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02505254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,8]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1996,8]]}},"alternative-id":["BF02505254"],"URL":"https:\/\/doi.org\/10.1007\/bf02505254","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,8]]}}}